PubRank

W Joost Lesterhuis

Author PubWeight™ 34.56‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol 2005 5.80
2 Dendritic cell immunotherapy: mapping the way. Nat Med 2004 4.28
3 Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res 2003 2.32
4 Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination. Cancer Res 2012 2.08
5 Programmed death ligand 2 in cancer-induced immune suppression. Clin Dev Immunol 2012 1.71
6 Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients. Clin Cancer Res 2003 1.57
7 Immunomonitoring tumor-specific T cells in delayed-type hypersensitivity skin biopsies after dendritic cell vaccination correlates with clinical outcome. J Clin Oncol 2005 1.48
8 Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patients. Clin Cancer Res 2010 1.45
9 Sensitivity of magnetic resonance imaging of dendritic cells for in vivo tracking of cellular cancer vaccines. Int J Cancer 2007 1.42
10 Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients. Clin Cancer Res 2009 1.24
11 Early identification of antigen-specific immune responses in vivo by [18F]-labeled 3'-fluoro-3'-deoxy-thymidine ([18F]FLT) PET imaging. Proc Natl Acad Sci U S A 2011 1.19
12 Phenotypical and functional characterization of clinical grade dendritic cells. J Immunother 2002 1.12
13 Vaccination with mRNA-electroporated dendritic cells induces robust tumor antigen-specific CD4+ and CD8+ T cells responses in stage III and IV melanoma patients. Clin Cancer Res 2012 1.11
14 Skin-test infiltrating lymphocytes early predict clinical outcome of dendritic cell-based vaccination in metastatic melanoma. Cancer Res 2012 1.03
15 Targeting of 111In-labeled dendritic cell human vaccines improved by reducing number of cells. Clin Cancer Res 2013 0.96
16 Polyinosinic polycytidylic acid prevents efficient antigen expression after mRNA electroporation of clinical grade dendritic cells. Cancer Immunol Immunother 2008 0.90
17 STATing the importance of immune modulation by platinum chemotherapeutics. Oncoimmunology 2012 0.89
18 PD-L2 is predominantly expressed by Th2 cells. Mol Immunol 2011 0.89
19 Acute generalised exanthematous pustulosis mimicking septic shock. Am J Med 2004 0.87
20 Neoadjuvant anti-tumor vaccination prior to surgery enhances survival. J Transl Med 2014 0.82
21 CDKN2A (INK4A-ARF) mutation analysis to distinguish cutaneous melanoma metastasis from a second primary melanoma. Am J Surg Pathol 2007 0.80
22 The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues. Cancer Immunol Immunother 2011 0.79
23 Colitis in an alcohol-dependent woman. Lancet 2007 0.75